1-butanol has been researched along with Parkinson Disease, Secondary in 1 studies
1-Butanol: A four carbon linear hydrocarbon that has a hydroxy group at position 1.
butan-1-ol : A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valálik, I | 1 |
| Emri, M | 1 |
| Lengyel, Z | 1 |
| Julow, J | 1 |
| Trón, L | 1 |
1 other study available for 1-butanol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
[Movement-activated [15O]-butanol PET scan in patients with Parkinson disease].
Topics: Butanols; Cerebrovascular Circulation; Humans; Motor Cortex; Movement; Oxygen Radioisotopes; Parkins | 2002 |